DR. HERBERT FALECK, D.O.
Medical Practice at Lakeview Dr, Town Center, NJ
License number
New Jersey 25MB03932800
Category
Medical Practice
Type
Pediatrics
Address
Address
19 Lakeview Dr, Town Center, NJ 07052
Phone
(973) 669-3547
Personal information
See more information about HERBERT FALECK at radaris.comName
Address
Phone
19 Lakeview Dr, West Orange, NJ 07052
Orange, NJ
19 Lakeview Dr, West Orange, NJ 07052
Organization information
See more information about HERBERT FALECK at bizstanding.comHerbert Faleck DO
19 Lakeview Dr, West Orange, NJ 07052
Industry:
Pediatrician
Herbert J. Faleck
Professional information
Methods And Compositions Using Immunomodulatory Compounds For The Treatment And Management Of Central Nervous System Disorders Or Diseases
US Patent:
2008022, Sep 18, 2008
Filed:
May 23, 2008
Appl. No.:
12/154575
Inventors:
Jerome B. Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Peter H. Schafer - Somerset NJ, US
Herbert Faleck - West Orange NJ, US
Peter H. Schafer - Somerset NJ, US
International Classification:
A61K 31/445, A61P 25/16, A61P 29/00
US Classification:
514323
Abstract:
Methods of treating, preventing and/or managing central nervous system disorders, such as Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) and related syndromes are disclosed. Specific methods encompass the administration of an immunomodulatory compound of the invention, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active ingredient. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods For Treatment, Modification And Management Of Radiculopathy Using 1-Oxo-2-(2,6-Dioxopiperidin-3Yl)-4-Aminoisoindoline
US Patent:
7612096, Nov 3, 2009
Filed:
Apr 23, 2004
Appl. No.:
10/576152
Inventors:
Jerome B. Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald C. Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald C. Manning - Bloomsbury NJ, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
A01N 43/40, A61K 31/445
US Classification:
514323, 514315, 514317, 514319, 514320
Abstract:
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Use Of Immunomodulatory Compounds For The Treatment Of Transverse Myelitis, Multiple Sclerosis, And Other Disorders
US Patent:
2009015, Jun 18, 2009
Filed:
Nov 26, 2008
Appl. No.:
12/324728
Inventors:
Robert J. Hariri - Bernardsville NJ, US
David I. Stirling - Branchburg NJ, US
Herbert Faleck - West Orange NJ, US
Anthony D. Radice - Summit NJ, US
David I. Stirling - Branchburg NJ, US
Herbert Faleck - West Orange NJ, US
Anthony D. Radice - Summit NJ, US
International Classification:
A61K 38/21, A61K 31/56, A61K 31/445, A61K 39/395
US Classification:
424 854, 514171, 514315, 4241301
Abstract:
Methods of treating, preventing or managing transverse myelitis, multiple sclerosis, and/or other disorders are disclosed. The methods encompass the administration of an immunomodulatory compound provided herein, such as 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl-piperidine-2,6-dione or 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline. Further described are methods of treatment using the immunomodulatory compounds in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed.
Methods And Compositions For The Treatment, Prevention Or Management Of Dysfunctional Sleep And Dysfunctional Sleep Associated With Disease
US Patent:
2005022, Oct 6, 2005
Filed:
Mar 30, 2005
Appl. No.:
11/093848
Inventors:
Jerome Zeldis - Princeton NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
International Classification:
A61K031/454
US Classification:
514323000
Abstract:
Methods of treating, preventing and/or managing dysfunctional sleep, including but not limited to, dysfunctional sleep associated with chronic neurological or inflammatory condition such as pain and neurodegenerative disorders, which comprise the administration of one or more immunomodulatory compounds or a pharmaceutically acceptable salt, solvate, stereoisomer, clathrate or prodrug thereof, alone or in combination with known therapeutics are disclosed. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods Of Diminishing Co-Abuse Potential
US Patent:
2009006, Mar 5, 2009
Filed:
Nov 12, 2008
Appl. No.:
12/269471
Inventors:
Vikram Khetani - Short Hills NJ, US
Herbert Faleck - West Orange NJ, US
Herbert Faleck - West Orange NJ, US
Assignee:
Celgene Corporation - Warren NJ
International Classification:
A61K 31/4418, A61K 31/445, A61P 25/30
US Classification:
514305, 514317
Abstract:
Methods of diminishing or eliminating the co-abuse of a methylphenidate drug comprising identifying a patient or patient group suspected or likely to abuse said methylphenidate drug in combination with a substance known or suspected to give rise to l-ethylphenidate or psychotropic effect when ingested in the combination and making available to said patent or patient group said methylphenidate drug substantially free of l-threo methylphenidate.
Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
US Patent:
2013005, Feb 28, 2013
Filed:
Oct 26, 2012
Appl. No.:
13/661472
Inventors:
Jerome B. Zeldis - Princeton NJ, US
Herbert J. Faleck - West Orange NJ, US
Vikram Khetani - Short Hills NJ, US
Andrew L. Zeitlin - Basking Ridge NJ, US
Maghsoud M. Dariani - Fanwood NJ, US
David I. Stirling - Branchburg NJ, US
Herbert J. Faleck - West Orange NJ, US
Vikram Khetani - Short Hills NJ, US
Andrew L. Zeitlin - Basking Ridge NJ, US
Maghsoud M. Dariani - Fanwood NJ, US
David I. Stirling - Branchburg NJ, US
International Classification:
A61K 31/4458, A61P 25/00, A61P 25/24, A61P 3/00
US Classification:
514317
Abstract:
In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invention is directed to methods for treating disorders related to menopause, including executive function defects. The methods involve the administration of a composition comprising -threo methylphenidate that is substantially free of -threo methylphenidate and of erythro forms of methylphenidate.
Methods Of Using And Compositions Comprising Immunomodulatory Compounds For Treatment, Modification And Management Of Pain
US Patent:
2005020, Sep 15, 2005
Filed:
Oct 23, 2003
Appl. No.:
10/693794
Inventors:
Jerome Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K031/454
US Classification:
514323000
Abstract:
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods Of Diminishing Co-Abuse Potential
US Patent:
2013015, Jun 20, 2013
Filed:
Feb 13, 2013
Appl. No.:
13/765994
Inventors:
Vikram Khetani - Short Hills NJ, US
Herbert Faleck - West Orange NJ, US
Herbert Faleck - West Orange NJ, US
International Classification:
A61K 31/4458
US Classification:
514317
Abstract:
Methods of diminishing or eliminating the co-abuse of a methylphenidate drug comprising identifying a patient or patient group suspected or likely to abuse said methylphenidate drug in combination with a substance known or suspected to give rise to l-ethylphenidate or psychotropic effect when ingested in the combination and making available to said patent or patient group said methylphenidate drug substantially free of l-threo methylphenidate.
Treatment Of Inflammatory Diseases Using Placental Stem Cells
US Patent:
2013034, Dec 26, 2013
Filed:
May 10, 2013
Appl. No.:
13/891732
Inventors:
Robert J. Hariri - Bernardsville NJ, US
Jia-Lun Wang - Cherry Hill NJ, US
Qian Ye - Livingston NJ, US
Herbert Faleck - West Orange NJ, US
Jia-Lun Wang - Cherry Hill NJ, US
Qian Ye - Livingston NJ, US
Herbert Faleck - West Orange NJ, US
Assignee:
Anthrogenesis Corporation - Warren NJ
International Classification:
A61K 35/50
US Classification:
424 937
Abstract:
Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.
Treatment Of Inflammatory Diseases Using Placental Stem Cells
US Patent:
8460650, Jun 11, 2013
Filed:
Feb 12, 2008
Appl. No.:
12/030161
Inventors:
James W. Edinger - Belford NJ, US
Robert J. Hariri - Florham Park NJ, US
Jia-Lun Wang - Cherry Hill NJ, US
Qian Ye - Livingston NJ, US
Herbert Faleck - West Orange NJ, US
Robert J. Hariri - Florham Park NJ, US
Jia-Lun Wang - Cherry Hill NJ, US
Qian Ye - Livingston NJ, US
Herbert Faleck - West Orange NJ, US
Assignee:
Anthrogenesis Corporation - Warren NJ
International Classification:
A01N 65/00
US Classification:
424 937, 424583, 424 931, 435325
Abstract:
Provided herein are methods of treatment of individuals having an immune-related disease, disorder or condition, for example, inflammatory bowel disease, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus erythematosus, diabetes, mycosis fungoides (Alibert-Bazin syndrome), or scleroderma using placental stem cells or umbilical cord stem cells.
Medical Practice licenses in New Jersey
TUTELA PLASTIC SURGERY PA, Medical Practice, 347 Mount Pleasant Ave SUITE 101, Town Center, NJ 07052